Prophylactic Risk Reducing Mastectomy (PRRM): Are we ready to Accept: Lower Middle-Income Country (LMIC) Perspective
暂无分享,去创建一个
[1] S. Kirmani,et al. Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan , 2022, Hereditary cancer in clinical practice.
[2] D. Evans,et al. Global Disparities in Breast Cancer Genetics Testing, Counselling and Management , 2019, World Journal of Surgery.
[3] A. Avan,et al. Hereditary breast cancer; Genetic penetrance and current status with BRCA , 2018, Journal of cellular physiology.
[4] E. Zabor,et al. Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance , 2017, Annals of Surgical Oncology.
[5] Ayesha Farooq,et al. Breast and Ovarian Cancer Risk due to Prevalence of BRCA1 and BRCA2 Variants in Pakistani Population: A Pakistani Database Report , 2011, Journal of oncology.